Status:
RECRUITING
Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients
Lead Sponsor:
Shinshu University
Conditions:
Osteoporosis
Eligibility:
All Genders
20-120 years
Phase:
PHASE2
Brief Summary
The aim of this study is to examine the efficacy and adverse events in the following 3 groups in Japanese osteoporosis patients after 2-year-denosumab therapy: SERM and eldecalcitol treatment for 24 ...
Eligibility Criteria
Inclusion
- osteoporosis patients
Exclusion
- not osteoporosis patients who are allergic to the drugs, refused to do this research, or who are pregnant
Key Trial Info
Start Date :
November 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 23 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03755193
Start Date
November 24 2018
End Date
November 23 2026
Last Update
September 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yukio Nakamura
Matsumoto, Nagano, Japan, 3908621